NextGen Health
Tirzepatide
Finnrick tested 3 samples of Tirzepatide (GLP-1 and GIP agonist) from NextGen Health between 11 Jun 2025 and 4 Nov 2025. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
NextGen Health
Tirzepatide
Tested 3 Samples
Last test 4 Nov 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from NextGen Health
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
4 Nov 2025
First
11 Jun 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 4 Nov 2025 | View | 10mg | 9.950mg | -0.5% | 99.68% | NG Peptide/Tirz/050625 | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 29 Jun 2025 | View | 30mg | 27.300mg | -9.0% | 99.80% | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 11 Jun 2025 | View | 20mg | 19.200mg | -4.0% | 99.81% | (no batch ID) | No Label / Silver Crimp / Grey Cap | Lab E | Public | |